Physician profile
Latoya Cameron
NPI 1619530425
$2,573.15
in general payments reported to CMS, 2019-2025
10 companies · $274 in 2025
The $274 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $515 · 2022: $1,589 · 2023: $66.50 · 2024: $128 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $469.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $468.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $1,209.30 | 2022 | |
| Alexion Pharmaceuticals, INC. | $331.29 | 2021-2025 | Koselugo |
| Biohaven Pharmaceuticals, INC. | $200.75 | 2021 | |
| Sk Life Science, INC. | $181.23 | 2021-2022 | |
| Amgen INC. | $165.79 | 2021-2025 | Uplizna |
| Argenx US, INC. | $162.00 | 2023-2025 | Vyvgart, Vyvgart Hytrulo |
| Nevro Corp. | $134.11 | 2022 | |
| Genzyme Corporation | $115.54 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $50.00 | 2025 | Wainua |
| Amneal Pharmaceuticals LLC | $23.14 | 2025 | Crexont |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Latoya Cameron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.